| 1 | Coffin-siris syndrome 1 | Enrichment | ARID1A, ARID1B, DPF2, SMARCA4, SMARCB1, SMARCC2, SMARCD1, SMARCE1 | 10.47 |
| 2 | Waardenburg syndrome, type 2e | Enrichment | EDNRB, KITLG, MITF, SNAI2, SOX10 | 10.41 |
| 3 | Waardenburg syndrome, type 4a | Enrichment | EDN3, EDNRB, MITF, SOX10 | 8.26 |
| 4 | Waardenburg syndrome | Enrichment | EDNRB, MITF, PAX3, SOX10 | 8.26 |
| 5 | Albinism | Enrichment | DCT, GPR143, TYR, TYRP1 | 7.35 |
| 6 | Bladder cancer | Enrichment | ARID1A, BRCA1, CDKN1A, CDKN2A, CTNNB1, TERT | 7.19 |
| 7 | Microcephaly | Enrichment | ACTB, ARID1A, ARID1B, CTNNB1, DIAPH1, EP300, IARS1, KARS1, MAPK1, QARS1, YWHAG | 6.86 |
| 8 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1, MET | 5.78 |
| 9 | Papillary renal cell carcinoma | Enrichment | MET, MITF | 5.78 |
| 10 | Deafness, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome | Enrichment | ATP6V1B2, ATP6V1C1 | 5.67 |
| 11 | Autosomal recessive cutis laxa type ii classic type | Enrichment | ATP6V1A, ATP6V1E1 | 5.67 |
| 12 | Waardenburg syndrome, type 1 | Enrichment | MITF, PAX3, SOX10 | 5.52 |
| 13 | Inherited cancer-predisposing syndrome | Enrichment | BRCA1, CDKN2A, DICER1, MET, MITF, SMARCA4, SMARCB1, SMARCE1 | 5.18 |
| 14 | Albinism, ocular, type i | Enrichment | GPR143, TYR, TYRP1 | 5.09 |
| 15 | Adrenocortical carcinoma | Enrichment | CDKN2A, CTNNB1, TERT | 5.09 |
| 16 | Piebald trait | Enrichment | KIT, SNAI2 | 4.70 |
| 17 | Melanoma, cutaneous malignant 1 | Enrichment | MITF, TERT | 4.66 |
| 18 | Colorectal cancer | Enrichment | ARID1A, BRCA1, CCND1, CTNNB1, EP300, MET, SOX9 | 4.25 |
| 19 | Griscelli syndrome, type 3 | Enrichment | MLPH, MYO5A | 4.25 |
| 20 | Vertebral anomalies and variable endocrine and t-cell dysfunction | Enrichment | DICER1, TBX2 | 4.25 |
| 21 | Melanoma, cutaneous malignant 8 | Enrichment | MITF, TYR | 4.25 |
| 22 | Rhabdoid tumor predisposition syndrome | Enrichment | SMARCA4, SMARCB1 | 4.25 |
| 23 | Waardenburg syndrome, type 2a | Enrichment | MITF, SOX10 | 4.23 |
| 24 | Melanoma | Enrichment | CDKN2A, MITF | 4.13 |
| 25 | Meningioma | Enrichment | SMARCB1, SMARCE1, TERT | 4.06 |
| 26 | Ovarian cancer | Enrichment | BRCA1, CDKN2A, CTNNB1, DICER1, MET, SMARCB1 | 3.95 |
| 27 | Rhabdomyosarcoma, embryonal, 2 | Enrichment | DICER1 | 3.83 |
| 28 | Dicer1 syndrome | Enrichment | DICER1 | 3.83 |
| 29 | Pleuropulmonary blastoma | Enrichment | DICER1 | 3.83 |
| 30 | Global developmental delay, lung cysts, overgrowth, and wilms tumor | Enrichment | DICER1 | 3.83 |
| 31 | Malignant sertoli-leydig cell tumor of ovary | Enrichment | DICER1 | 3.83 |
| 32 | Supratentorial primitive neuroectodermal tumor | Enrichment | DICER1 | 3.83 |
| 33 | Gynandroblastoma | Enrichment | DICER1 | 3.83 |
| 34 | Dicer1 tumor predisposition | Enrichment | DICER1 | 3.83 |
| 35 | Rare genetic deafness | Enrichment | DIAPH1, MITF | 3.70 |
| 36 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | MCM2, MITF | 3.67 |
| 37 | Heterochromia iridis | Enrichment | MITF | 3.66 |
| 38 | Tietz albinism-deafness syndrome | Enrichment | MITF | 3.66 |
| 39 | Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness | Enrichment | MITF | 3.66 |
| 40 | Hereditary breast ovarian cancer syndrome | Enrichment | BRCA1, MITF | 3.62 |
| 41 | Hirschsprung disease 1 | Enrichment | EDN3, EDNRB, SOX10 | 3.54 |
| 42 | Goiter, multinodular 1, with or without sertoli-leydig cell tumors | Enrichment | DICER1 | 3.53 |
| 43 | Pineoblastoma | Enrichment | DICER1 | 3.53 |
| 44 | Malignant granulosa cell tumor of the ovary | Enrichment | DICER1 | 3.53 |
| 45 | Deafness, autosomal dominant 1, with or without thrombocytopenia | Enrichment | DIAPH1 | 3.53 |
| 46 | Seizures, cortical blindness, and microcephaly syndrome | Enrichment | DIAPH1 | 3.53 |
| 47 | Diaph1-related sensorineural hearing loss-thrombocytopenia syndrome | Enrichment | DIAPH1 | 3.53 |
| 48 | Rubinstein-taybi syndrome 1 | Enrichment | CREBBP, EP300 | 3.53 |
| 49 | Testicular germ cell tumor | Enrichment | KIT, KITLG | 3.53 |
| 50 | Chromosome 16p13.3 deletion syndrome, proximal | Enrichment | CREBBP, EP300 | 3.53 |
| 51 | Nicolaides-baraitser syndrome | Enrichment | ARID1B, SMARCA2 | 3.48 |
| 52 | Blepharophimosis | Enrichment | ARID1B, SMARCA2 | 3.48 |
| 53 | Smarca2-related nicolaides-baraitser syndrome | Enrichment | ARID1B, SMARCA2 | 3.48 |
| 54 | Pseudomyogenic hemangioendothelioma | Enrichment | ACTB, SERPINE1 | 3.48 |
| 55 | Intraocular pressure quantitative trait locus | Enrichment | CREBBP, ZEB1 | 3.42 |
| 56 | Renal cell carcinoma | Enrichment | MET, TFE3 | 3.42 |
| 57 | Hepatocellular carcinoma | Enrichment | CTNNB1, MET | 3.42 |
| 58 | Renal cell carcinoma with mit translocations | Enrichment | TFE3, TFEB | 3.39 |
| 59 | Corneal dystrophy, posterior polymorphous, 3 | Enrichment | ZEB1 | 3.35 |
| 60 | Corneal dystrophy, fuchs endothelial, 6 | Enrichment | ZEB1 | 3.35 |
| 61 | Palmoplantar keratoderma, punctate type ii | Enrichment | BRCA1 | 3.35 |
| 62 | Infant-type hemispheric glioma | Enrichment | BRCA1 | 3.35 |
| 63 | Deafness, autosomal dominant 70 | Enrichment | MCM2 | 3.35 |
| 64 | Meier-gorlin syndrome 8 | Enrichment | MCM5 | 3.35 |
| 65 | Immunodeficiency 96 | Enrichment | LIG1 | 3.35 |
| 66 | Autosomal recessive dyskeratosis congenita 4 | Enrichment | TERT | 3.35 |
| 67 | Primary peritoneal carcinoma | Enrichment | BRCA1 | 3.35 |
| 68 | Complex neurodevelopmental disorder | Enrichment | AGO1, AGO2, TNRC6B | 3.26 |
| 69 | Corpus callosum, agenesis of | Enrichment | ARID1B, CDH2, CREBBP | 3.24 |
| 70 | Isolated corpus callosum agenesis | Enrichment | ARID1B, CDH2, CREBBP | 3.24 |
| 71 | Rare genetic intellectual disability | Enrichment | ARID1B, CREBBP, EP300 | 3.24 |
| 72 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | ARID1B, CDH2, CREBBP | 3.24 |
| 73 | Embryonal rhabdomyosarcoma | Enrichment | DICER1 | 3.23 |
| 74 | Corneal dystrophy | Enrichment | ZEB1 | 3.23 |
| 75 | Fuchs' endothelial dystrophy | Enrichment | ZEB1 | 3.13 |
| 76 | Agenesis of corpus callosum, cardiac, ocular, and genital syndrome | Enrichment | CDH2 | 3.09 |
| 77 | Plasminogen activator inhibitor-1 deficiency | Enrichment | SERPINE1 | 3.09 |
| 78 | Arrhythmogenic right ventricular dysplasia, familial, 14 | Enrichment | CDH2 | 3.09 |
| 79 | Attention deficit-hyperactivity disorder 8 | Enrichment | CDH2 | 3.09 |
| 80 | Fetomaternal alloimmune thrombocytopenia 3 | Enrichment | ITGA2 | 3.09 |
| 81 | Congenital plasminogen activator inhibitor type 1 deficiency | Enrichment | SERPINE1 | 3.09 |
| 82 | Clear cell papillary renal cell carcinoma | Enrichment | MITF | 3.05 |
| 83 | Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 1 | Enrichment | TERT | 3.05 |
| 84 | Fanconi anemia, complementation group s | Enrichment | BRCA1 | 3.05 |
| 85 | Pancreatic cancer 4 | Enrichment | BRCA1 | 3.05 |
| 86 | Melanoma, cutaneous malignant 9 | Enrichment | TERT | 3.05 |
| 87 | Idiopathic interstitial pneumonia | Enrichment | TERT | 3.05 |
| 88 | Inflammatory breast carcinoma | Enrichment | BRCA1 | 3.05 |
| 89 | Peritoneum cancer | Enrichment | BRCA1 | 3.05 |
| 90 | Bilateral breast cancer | Enrichment | BRCA1 | 3.05 |
| 91 | Corneal dystrophy, posterior polymorphous, 1 | Enrichment | ZEB1 | 3.05 |
| 92 | Deafness, congenital, with onychodystrophy, autosomal dominant | Enrichment | ATP6V1B2 | 3.05 |
| 93 | Keloid formation | Enrichment | ASAH1 | 3.05 |
| 94 | Cutis laxa, autosomal recessive, type iid | Enrichment | ATP6V1A | 3.05 |
| 95 | Zimmermann-laband syndrome 2 | Enrichment | ATP6V1B2 | 3.05 |
| 96 | Cutis laxa, autosomal recessive, type iic | Enrichment | ATP6V1E1 | 3.05 |
| 97 | Asah1-related disorders | Enrichment | ASAH1 | 3.05 |
| 98 | Epilepsy, early-onset, 3, with or without developmental delay | Enrichment | ATP6V0C | 3.05 |
| 99 | Autosomal dominant deafness - onychodystrophy syndrome | Enrichment | ATP6V1B2 | 3.05 |
| 100 | Specific learning disability | Enrichment | MAPK1, YWHAG | 2.97 |
| 101 | Oculocutaneous albinism | Enrichment | TYR, TYRP1 | 2.94 |
| 102 | Albinism, oculocutaneous, type ii | Enrichment | MC1R, TYRP1 | 2.91 |
| 103 | Interstitial lung disease | Enrichment | TERT | 2.88 |
| 104 | Macrocytic anemia | Enrichment | TERT | 2.88 |
| 105 | Neuromyotonia and axonal neuropathy, autosomal recessive | Enrichment | HINT1 | 2.88 |
| 106 | Ectodermal dysplasia 17 with or without limb malformations | Enrichment | LEF1 | 2.88 |
| 107 | Osteofibrous dysplasia | Enrichment | MET | 2.88 |
| 108 | Deafness, autosomal recessive 97 | Enrichment | MET | 2.88 |
| 109 | Autism 9 | Enrichment | MET | 2.88 |
| 110 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 2.88 |
| 111 | Arthrogryposis, distal, type 11 | Enrichment | MET | 2.88 |
| 112 | Cdkn2a cancer predisposition | Enrichment | CDKN2A | 2.88 |
| 113 | Chromosome 15q24 deletion syndrome | Enrichment | SIN3A | 2.88 |
| 114 | Microcystic stromal tumor | Enrichment | CTNNB1 | 2.88 |
| 115 | Global developmental delay with speech and behavioral abnormalities | Enrichment | TNRC6B | 2.88 |
| 116 | Epilepsy, familial adult myoclonic, 6 | Enrichment | TNRC6A | 2.88 |
| 117 | Body mass index quantitative trait locus 11 | Enrichment | MC3R, MC4R, POMC | 2.84 |
| 118 | Anterior segment dysgenesis 7 | Enrichment | PXDN | 2.79 |
| 119 | Congenital disorder of glycosylation, type ix | Enrichment | STT3B | 2.79 |
| 120 | Intellectual developmental disorder, autosomal dominant 39 | Enrichment | PXDN | 2.79 |
| 121 | Polyposis syndrome, hereditary mixed, 1 | Enrichment | BRCA1 | 2.75 |
| 122 | Cholangiocarcinoma | Enrichment | BRCA1 | 2.75 |
| 123 | Lung sarcomatoid carcinoma | Enrichment | TERT | 2.75 |
| 124 | Moyamoya disease 1 | Enrichment | DIAPH1 | 2.75 |
| 125 | Pendred syndrome | Enrichment | DIAPH1 | 2.75 |
| 126 | Spinal muscular atrophy with progressive myoclonic epilepsy | Enrichment | ASAH1 | 2.75 |
| 127 | Farber lipogranulomatosis | Enrichment | ASAH1 | 2.75 |
| 128 | Developmental and epileptic encephalopathy 93 | Enrichment | ATP6V1A | 2.75 |
| 129 | Childhood-onset epilepsy syndrome | Enrichment | ATP6V0C | 2.75 |
| 130 | Hypertrichosis | Enrichment | ARID1B, CREBBP | 2.74 |
| 131 | Kidney clear cell sarcoma | Enrichment | TERT, YWHAE | 2.74 |
| 132 | Breast-ovarian cancer, familial 2 | Enrichment | BRCA1 | 2.66 |
| 133 | Idiopathic aplastic anemia | Enrichment | TERT | 2.66 |
| 134 | Rhabdomyosarcoma | Enrichment | DICER1 | 2.63 |
| 135 | Dyskeratosis congenita, autosomal dominant 1 | Enrichment | TERT | 2.58 |
| 136 | Pulmonary fibrosis | Enrichment | TERT | 2.58 |
| 137 | Hoyeraal-hreidarsson syndrome | Enrichment | TERT | 2.58 |
| 138 | Zimmermann-laband syndrome 1 | Enrichment | ATP6V1B2 | 2.58 |
| 139 | Ectrodactyly and ectodermal dysplasia without cleft lip/palate | Enrichment | LEF1 | 2.58 |
| 140 | Melanoma-astrocytoma syndrome | Enrichment | CDKN2A | 2.58 |
| 141 | Osteopathia striata with cranial sclerosis | Enrichment | CTNNB1 | 2.58 |
| 142 | Melanoma, cutaneous malignant 2 | Enrichment | CDKN2A | 2.58 |
| 143 | Split hand-foot malformation | Enrichment | LEF1 | 2.58 |
| 144 | Melanoma-pancreatic cancer syndrome | Enrichment | CDKN2A | 2.58 |
| 145 | Witteveen-kolk syndrome | Enrichment | SIN3A | 2.58 |
| 146 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 2.58 |
| 147 | Teratoma | Enrichment | CTNNB1 | 2.58 |
| 148 | Premature ovarian failure 3 | Enrichment | AGO2 | 2.58 |
| 149 | Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures | Enrichment | AGO1 | 2.58 |
| 150 | Intravascular large b-cell lymphoma | Enrichment | BCL2 | 2.58 |
| 151 | Meningioma, familial | Enrichment | SMARCB1, SMARCE1 | 2.53 |
| 152 | Atrial heart septal defect | Enrichment | ACTL6A, SMARCA4 | 2.53 |
| 153 | Interatrial communication | Enrichment | ACTL6A, SMARCA4 | 2.53 |
| 154 | Dyskeratosis congenita, autosomal dominant 2 | Enrichment | TERT | 2.51 |
| 155 | Microphthalmia, syndromic 3 | Enrichment | SOX2 | 2.49 |
| 156 | Septooptic dysplasia | Enrichment | ARID1A, SOX2 | 2.45 |
| 157 | Leukodystrophy | Enrichment | KARS1, RARS1 | 2.45 |
| 158 | Desmoid disease, hereditary | Enrichment | CTNNB1 | 2.40 |
| 159 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 2.40 |
| 160 | Anus, imperforate | Enrichment | CTNNB1 | 2.40 |
| 161 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 2.40 |
| 162 | Desmoid tumor | Enrichment | CTNNB1 | 2.40 |
| 163 | High-grade b-cell lymphoma double-hit/triple-hit | Enrichment | BCL2 | 2.40 |
| 164 | Lessel-kreienkamp syndrome | Enrichment | AGO2 | 2.40 |
| 165 | Aplastic anemia | Enrichment | TERT | 2.35 |
| 166 | Craniofacial-deafness-hand syndrome | Enrichment | PAX3 | 2.35 |
| 167 | Frontonasal dysplasia 1 | Enrichment | ALX3 | 2.35 |
| 168 | Waardenburg syndrome, type 3 | Enrichment | PAX3 | 2.35 |
| 169 | Leukodystrophy, hypomyelinating, 3 | Enrichment | AIMP1 | 2.35 |
| 170 | Body mass index quantitative trait locus 9 | Enrichment | MC3R | 2.35 |
| 171 | Mastocytosis, cutaneous | Enrichment | KIT | 2.35 |
| 172 | Infantile liver failure syndrome 1 | Enrichment | LARS1 | 2.35 |
| 173 | Hyperpigmentation with or without hypopigmentation, familial progressive | Enrichment | KITLG | 2.35 |
| 174 | Increased analgesia from kappa-opioid receptor agonist, female-specific | Enrichment | MC1R | 2.35 |
| 175 | Craniosynostosis 6 | Enrichment | ZIC1 | 2.35 |
| 176 | Hirschsprung disease 4 | Enrichment | EDN3 | 2.35 |
| 177 | Waardenburg syndrome, type 4b | Enrichment | EDN3 | 2.35 |
| 178 | Auriculocondylar syndrome 3 | Enrichment | EDN1 | 2.35 |
| 179 | Noonan syndrome 13 | Enrichment | MAPK1 | 2.35 |
| 180 | 46,xy sex reversal 10 | Enrichment | SOX9 | 2.35 |
| 181 | Skin/hair/eye pigmentation, variation in, 2 | Enrichment | MC1R | 2.35 |
| 182 | 46,xx sex reversal 2 | Enrichment | SOX9 | 2.35 |
| 183 | Orofacial cleft 10 | Enrichment | SUMO1 | 2.35 |
| 184 | Renal cell carcinoma, xp11-associated | Enrichment | TFE3 | 2.35 |
| 185 | Intellectual developmental disorder, x-linked, syndromic, with pigmentary mosaicism and coarse facies | Enrichment | TFE3 | 2.35 |
| 186 | Body mass index quantitative trait locus 20 | Enrichment | MC4R | 2.35 |
| 187 | Charcot-marie-tooth disease, recessive intermediate b | Enrichment | KARS1 | 2.35 |
| 188 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 | Enrichment | AKT3 | 2.35 |
| 189 | Skin/hair/eye pigmentation, variation in, 7 | Enrichment | KITLG | 2.35 |
| 190 | Growth retardation, impaired intellectual development, hypotonia, and hepatopathy | Enrichment | IARS1 | 2.35 |
| 191 | Leukodystrophy, hypomyelinating, 9 | Enrichment | RARS1 | 2.35 |
| 192 | Question mark ears, isolated | Enrichment | EDN1 | 2.35 |
| 193 | Melanoma, cutaneous malignant 5 | Enrichment | MC1R | 2.35 |
| 194 | Developmental and epileptic encephalopathy 56 | Enrichment | YWHAG | 2.35 |
| 195 | Hypomyelination with brainstem and spinal cord involvement and leg spasticity | Enrichment | DARS1 | 2.35 |
| 196 | Structural brain anomalies with impaired intellectual development and craniosynostosis | Enrichment | ZIC1 | 2.35 |
| 197 | Visual impairment and progressive phthisis bulbi | Enrichment | MARK3 | 2.35 |
| 198 | Charcot-marie-tooth disease, axonal, type 2u | Enrichment | MARS1 | 2.35 |
| 199 | Leukodystrophy, hypomyelinating, 15 | Enrichment | EPRS1 | 2.35 |
| 200 | Trichothiodystrophy 9, nonphotosensitive | Enrichment | MARS1 | 2.35 |
| 201 | Menke-hennekam syndrome 1 | Enrichment | CREBBP | 2.35 |
| 202 | Chronic mast cell leukemia | Enrichment | KIT | 2.35 |
| 203 | Obesity due to melanocortin 4 receptor deficiency | Enrichment | MC4R | 2.35 |
| 204 | Leukoencephalopathy, progressive, infantile-onset, with or without deafness | Enrichment | KARS1 | 2.35 |
| 205 | Deafness, autosomal dominant 69 | Enrichment | KITLG | 2.35 |
| 206 | Rubinstein-taybi syndrome due to 16p13.3 microdeletion | Enrichment | CREBBP | 2.35 |
| 207 | Capillary hemangioma | Enrichment | AKT3 | 2.35 |
| 208 | Isolated bone marrow mastocytosis | Enrichment | KIT | 2.35 |
| 209 | Smoldering systemic mastocytosis | Enrichment | KIT | 2.35 |
| 210 | Mastocytosis | Enrichment | KIT | 2.35 |
| 211 | Menke-hennekam syndrome | Enrichment | CREBBP | 2.35 |
| 212 | Pulmonary alveolar proteinosis | Enrichment | MARS1 | 2.35 |
| 213 | Familial progressive hyperpigmentation | Enrichment | KITLG | 2.35 |
| 214 | Cutaneous mastocytoma | Enrichment | KIT | 2.35 |
| 215 | Typical urticaria pigmentosa | Enrichment | KIT | 2.35 |
| 216 | Nodular urticaria pigmentosa | Enrichment | KIT | 2.35 |
| 217 | Pseudoxanthomatous diffuse cutaneous mastocytosis | Enrichment | KIT | 2.35 |
| 218 | Telangiectasia macularis eruptiva perstans | Enrichment | KIT | 2.35 |
| 219 | Acute mast cell leukemia | Enrichment | KIT | 2.35 |
| 220 | Distal 17p13.3 microdeletion syndrome | Enrichment | YWHAE | 2.35 |
| 221 | Familial progressive hyper- and hypopigmentation | Enrichment | KITLG | 2.35 |
| 222 | Plaque-form urticaria pigmentosa | Enrichment | KIT | 2.35 |
| 223 | Bullous diffuse cutaneous mastocytosis | Enrichment | KIT | 2.35 |
| 224 | Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome | Enrichment | QARS1 | 2.35 |
| 225 | Testis seminoma | Enrichment | KIT | 2.35 |
| 226 | Fetomaternal alloimmune thrombocytopenia 1 | Enrichment | ITGA2 | 2.31 |
| 227 | Uterine corpus cancer | Enrichment | BRCA1 | 2.31 |
| 228 | Pilomatrixoma | Enrichment | CTNNB1 | 2.28 |
| 229 | Alazami syndrome | Enrichment | CTNNB1 | 2.28 |
| 230 | Mantle cell lymphoma | Enrichment | CCND1 | 2.28 |
| 231 | Craniopharyngioma | Enrichment | CTNNB1 | 2.28 |
| 232 | Ear malformation | Enrichment | MITF | 2.28 |
| 233 | Optic nerve disease | Enrichment | KARS1, TYR | 2.27 |
| 234 | Glaucoma 3, primary congenital, a | Enrichment | PXDN | 2.25 |
| 235 | Breast-ovarian cancer, familial 1 | Enrichment | BRCA1 | 2.24 |
| 236 | Periventricular nodular heterotopia | Enrichment | BRCA1 | 2.21 |
| 237 | Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay | Enrichment | ARID1A, ARID1B | 2.20 |
| 238 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1 | 2.18 |
| 239 | Von hippel-lindau syndrome | Enrichment | CCND1 | 2.18 |
| 240 | Night blindness, congenital stationary, type 1c | Enrichment | TRPM1 | 2.18 |
| 241 | Follicular lymphoma | Enrichment | BCL2 | 2.18 |
| 242 | Night blindness | Enrichment | TRPM1 | 2.18 |
| 243 | Interstitial lung disease 2 | Enrichment | TERT | 2.13 |
| 244 | Hypoinsulinemic hypoglycemia with hemihypertrophy | Enrichment | AKT2 | 2.12 |
| 245 | Torticollis | Enrichment | ACTL6A | 2.12 |
| 246 | Nystagmus 6, congenital, x-linked | Enrichment | GPR143 | 2.12 |
| 247 | Baraitser-winter syndrome 1 | Enrichment | ACTB | 2.12 |
| 248 | Griscelli syndrome, type 2 | Enrichment | RAB27A | 2.12 |
| 249 | Hyperlipidemia, familial combined, 1 | Enrichment | USF1 | 2.12 |
| 250 | Albinism, oculocutaneous, type ib | Enrichment | TYR | 2.12 |
| 251 | Skin/hair/eye pigmentation, variation in, 8 | Enrichment | IRF4 | 2.12 |
| 252 | Coffin-siris syndrome 5 | Enrichment | SMARCE1 | 2.12 |
| 253 | Griscelli syndrome, type 1 | Enrichment | MYO5A | 2.12 |
| 254 | Elejalde neuroectodermal melanolysosomal syndrome | Enrichment | MYO5A | 2.12 |
| 255 | Skin/hair/eye pigmentation, variation in, 3 | Enrichment | TYR | 2.12 |
| 256 | Coffin-siris syndrome 11 | Enrichment | SMARCD1 | 2.12 |
| 257 | Hydrocephalus, congenital, 5 | Enrichment | SMARCC1 | 2.12 |
| 258 | Immunodeficiency 131 | Enrichment | IRF4 | 2.12 |
| 259 | Congenital smooth muscle hamartoma, with or without hemihypertrophy | Enrichment | ACTB | 2.12 |
| 260 | Becker nevus syndrome | Enrichment | ACTB | 2.12 |
| 261 | Dystonia-deafness syndrome 1 | Enrichment | ACTB | 2.12 |
| 262 | Rhabdoid tumor predisposition syndrome 1 | Enrichment | SMARCB1 | 2.12 |
| 263 | Neurilemmoma | Enrichment | SMARCB1 | 2.12 |
| 264 | Coffin-siris syndrome 3 | Enrichment | SMARCB1 | 2.12 |
| 265 | Smarca4-deficient sarcoma of thorax | Enrichment | SMARCA4 | 2.12 |
| 266 | Arid1b-related disorder | Enrichment | ARID1B | 2.12 |
| 267 | Ovarian small cell carcinoma | Enrichment | SMARCA4 | 2.12 |
| 268 | Blepharophimosis-impaired intellectual development syndrome | Enrichment | SMARCA2 | 2.12 |
| 269 | Coffin-siris syndrome 7 | Enrichment | DPF2 | 2.12 |
| 270 | Thrombocytopenia 8, with dysmorphic features and developmental delay | Enrichment | ACTB | 2.12 |
| 271 | Griscelli syndrome | Enrichment | RAB27A | 2.12 |
| 272 | Baraitser-winter syndrome | Enrichment | ACTB | 2.12 |
| 273 | Facial cleft | Enrichment | SMARCE1 | 2.12 |
| 274 | Minimal pigment oculocutaneous albinism type 1 | Enrichment | TYR | 2.12 |
| 275 | Autosomal recessive severe congenital neutropenia | Enrichment | SMARCD2 | 2.12 |
| 276 | Congenital smooth muscle hamartoma | Enrichment | ACTB | 2.12 |
| 277 | Developmental malformations-deafness-dystonia syndrome | Enrichment | ACTB | 2.12 |
| 278 | Whipple disease | Enrichment | IRF4 | 2.12 |
| 279 | Hypopigmentation of the skin | Enrichment | TYR | 2.12 |
| 280 | Akt2-related familial partial lipodystrophy | Enrichment | AKT2 | 2.12 |
| 281 | Auditory neuropathy | Enrichment | DIAPH1 | 2.12 |
| 282 | Lip and oral cavity carcinoma | Enrichment | CDKN2A, KIT | 2.11 |
| 283 | Li-fraumeni syndrome | Enrichment | CDKN2A | 2.10 |
| 284 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 2.10 |
| 285 | Split-hand/foot malformation 1 | Enrichment | LEF1 | 2.10 |
| 286 | Lung squamous cell carcinoma | Enrichment | CDKN2A | 2.10 |
| 287 | Non-syndromic genetic deafness | Enrichment | MITF | 2.10 |
| 288 | Dyskeratosis congenita | Enrichment | TERT | 2.08 |
| 289 | Nanophthalmos | Enrichment | SOX2 | 2.05 |
| 290 | Campomelic dysplasia | Enrichment | SOX9 | 2.05 |
| 291 | Aganglionosis, total intestinal | Enrichment | EDNRB | 2.05 |
| 292 | Thumb deformity | Enrichment | CREBBP | 2.05 |
| 293 | Ulnar-mammary syndrome | Enrichment | TBX3 | 2.05 |
| 294 | Abcd syndrome | Enrichment | EDNRB | 2.05 |
| 295 | Alveolar soft part sarcoma | Enrichment | TFE3 | 2.05 |
| 296 | Histiocytoma, angiomatoid fibrous | Enrichment | CREB1 | 2.05 |
| 297 | Waardenburg syndrome, type 4c | Enrichment | SOX10 | 2.05 |
| 298 | Intellectual developmental disorder, autosomal dominant 43 | Enrichment | QARS1 | 2.05 |
| 299 | Osteopetrosis, autosomal recessive 2 | Enrichment | TNFSF11 | 2.05 |
| 300 | Waardenburg syndrome, type 2f | Enrichment | KITLG | 2.05 |
| 301 | Deafness, congenital, and adult-onset progressive leukoencephalopathy | Enrichment | KARS1 | 2.05 |
| 302 | Spastic paraplegia 70, autosomal recessive | Enrichment | MARS1 | 2.05 |
| 303 | Menke-hennekam syndrome 2 | Enrichment | EP300 | 2.05 |
| 304 | Deafness, autosomal recessive 89 | Enrichment | KARS1 | 2.05 |
| 305 | Leukodystrophy, hypomyelinating, 17 | Enrichment | AIMP2 | 2.05 |
| 306 | Acute myeloid leukemia with kat6a-crebbp fusion | Enrichment | CREBBP | 2.05 |
| 307 | Senior-loken syndrome 7 | Enrichment | AKT3 | 2.05 |
| 308 | Peripheral demyelinating neuropathy, central dysmyelination, waardenburg syndrome, and hirschsprung disease | Enrichment | SOX10 | 2.05 |
| 309 | Interstitial lung and liver disease | Enrichment | MARS1 | 2.05 |
| 310 | Bardet-biedl syndrome 16 | Enrichment | AKT3 | 2.05 |
| 311 | Isolated dandy-walker malformation with hydrocephalus | Enrichment | ZIC1 | 2.05 |
| 312 | Primary mediastinal large b-cell lymphoma | Enrichment | XPO1 | 2.05 |
| 313 | B-lymphoblastic leukemia/lymphoma with t | Enrichment | KIT | 2.05 |
| 314 | Campomelic dysplasia and related disorders | Enrichment | SOX9 | 2.05 |
| 315 | Multiple endocrine neoplasia, type i | Enrichment | CDKN1A | 2.03 |
| 316 | Renal cell carcinoma, papillary, 1 | Enrichment | MET | 2.03 |
| 317 | Gallbladder cancer | Enrichment | CTNNB1 | 2.03 |
| 318 | B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) | Enrichment | CDKN2A | 2.03 |
| 319 | Endometrial cancer | Enrichment | BRCA1 | 2.03 |
| 320 | Hepatoblastoma | Enrichment | TERT | 2.03 |
| 321 | Nonsyndromic hearing loss | Enrichment | MITF | 2.03 |
| 322 | Cutis laxa | Enrichment | ATP6V1E1 | 1.98 |
| 323 | Arthrogryposis, distal, type 1a | Enrichment | MET | 1.98 |
| 324 | Exudative vitreoretinopathy | Enrichment | CTNNB1 | 1.98 |
| 325 | Pancreatic cancer | Enrichment | BRCA1 | 1.96 |
| 326 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | CDH2 | 1.95 |
| 327 | Microphthalmia | Enrichment | SOX2, TFAP2A | 1.93 |
| 328 | Epilepsy | Enrichment | DIAPH1 | 1.93 |
| 329 | Adult hepatocellular carcinoma | Enrichment | CTNNB1 | 1.93 |
| 330 | Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies | Enrichment | TNRC6B | 1.93 |
| 331 | Anterior segment dysgenesis | Enrichment | PXDN | 1.92 |
| 332 | Prostate cancer | Enrichment | BRCA1 | 1.89 |
| 333 | Differentiated thyroid carcinoma | Enrichment | TERT | 1.89 |
| 334 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | PPARGC1A | 1.89 |
| 335 | Leukemia, chronic lymphocytic | Enrichment | CCND1 | 1.88 |
| 336 | Hirschsprung disease 2 | Enrichment | EDNRB | 1.87 |
| 337 | 46,xx sex reversal 1 | Enrichment | SOX9 | 1.87 |
| 338 | Obesity, early-onset, with adrenal insufficiency and red hair | Enrichment | POMC | 1.87 |
| 339 | Autoimmune disease 1 | Enrichment | FOXD3 | 1.87 |
| 340 | Osteoporosis, juvenile | Enrichment | WNT3A | 1.87 |
| 341 | Miller-dieker lissencephaly syndrome | Enrichment | YWHAE | 1.87 |
| 342 | Chromosome 17p13.3, centromeric, duplication syndrome | Enrichment | YWHAE | 1.87 |
| 343 | Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy | Enrichment | QARS1 | 1.87 |
| 344 | Tethered spinal cord syndrome | Enrichment | CREBBP | 1.87 |
| 345 | Testicular germ cell cancer | Enrichment | KIT | 1.87 |
| 346 | Melanoma of soft tissue | Enrichment | CREB1 | 1.87 |
| 347 | Isolated dandy-walker malformation without hydrocephalus | Enrichment | ZIC1 | 1.87 |
| 348 | Obesity due to pro-opiomelanocortin deficiency | Enrichment | POMC | 1.87 |
| 349 | Lung cancer | Enrichment | BRCA1 | 1.85 |
| 350 | Leukemia, acute lymphoblastic | Enrichment | CDKN2A | 1.84 |
| 351 | Alopecia, androgenetic, 1 | Enrichment | SMARCD1 | 1.82 |
| 352 | Albinism, oculocutaneous, type iii | Enrichment | TYRP1 | 1.82 |
| 353 | Trichomegaly | Enrichment | ARID1B | 1.82 |
| 354 | Specific granule deficiency 1 | Enrichment | SMARCD2 | 1.82 |
| 355 | Rhabdoid tumor predisposition syndrome 2 | Enrichment | SMARCA4 | 1.82 |
| 356 | Schwannomatosis 1 | Enrichment | SMARCB1 | 1.82 |
| 357 | Chromosome 6q24-q25 deletion syndrome | Enrichment | ARID1B | 1.82 |
| 358 | Albinism, oculocutaneous, type ia | Enrichment | TYR | 1.82 |
| 359 | Skin/hair/eye pigmentation, variation in, 11 | Enrichment | TYRP1 | 1.82 |
| 360 | Oculocutaneous albinism, type viii | Enrichment | DCT | 1.82 |
| 361 | Severe combined immunodeficiency with sensitivity to ionizing radiation | Enrichment | ARID1B | 1.82 |
| 362 | Specific granule deficiency 2 | Enrichment | SMARCD2 | 1.82 |
| 363 | Coffin-siris syndrome 8 | Enrichment | SMARCC2 | 1.82 |
| 364 | Otosclerosis 12 | Enrichment | SMARCA4 | 1.82 |
| 365 | Coffin-siris syndrome 4 | Enrichment | SMARCA4 | 1.82 |
| 366 | Baraitser-winter cerebrofrontofacial syndrome | Enrichment | ACTB | 1.82 |
| 367 | Esotropia | Enrichment | TFAP2A | 1.82 |
| 368 | Blepharophimosis - intellectual disability syndrome | Enrichment | SMARCA2 | 1.82 |
| 369 | Lens subluxation | Enrichment | TFAP2A | 1.82 |
| 370 | Specific granule deficiency | Enrichment | SMARCD2 | 1.82 |
| 371 | Arteriovenous malformations of the brain | Enrichment | CDH2 | 1.82 |
| 372 | Fanconi anemia, complementation group a | Enrichment | BRCA1 | 1.81 |
| 373 | Macs syndrome | Enrichment | SOX2 | 1.79 |
| 374 | Leukemia, acute myeloid | Enrichment | TERT | 1.76 |
| 375 | Auriculocondylar syndrome 1 | Enrichment | EDN1 | 1.75 |
| 376 | Megalencephaly-capillary malformation-polymicrogyria syndrome | Enrichment | AKT3 | 1.75 |
| 377 | Chromosome 22q11.2 deletion syndrome, distal | Enrichment | MAPK1 | 1.75 |
| 378 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 | Enrichment | AKT3 | 1.75 |
| 379 | Malignant epithelioid hemangioendothelioma | Enrichment | TFE3 | 1.75 |
| 380 | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia | Enrichment | YWHAZ | 1.75 |
| 381 | Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) | Enrichment | KIT | 1.75 |
| 382 | Autosomal recessive osteopetrosis | Enrichment | TNFSF11 | 1.75 |
| 383 | Non-syndromic bicoronal craniosynostosis | Enrichment | ZIC1 | 1.75 |
| 384 | Systemic mastocytosis with associated hematologic neoplasm | Enrichment | KIT | 1.75 |
| 385 | Medulloblastoma | Enrichment | CTNNB1 | 1.73 |
| 386 | Gastric cancer | Enrichment | BRCA1 | 1.72 |
| 387 | Hereditary breast carcinoma | Enrichment | BRCA1 | 1.71 |
| 388 | Sensorineural hearing loss | Enrichment | EDN3, KARS1 | 1.71 |
| 389 | Renal cell carcinoma, nonpapillary | Enrichment | MET | 1.70 |
| 390 | Hypogonadotropic hypogonadism 1 with or without anosmia | Enrichment | SOX10 | 1.65 |
| 391 | Rhabdomyosarcoma 2 | Enrichment | PAX3 | 1.65 |
| 392 | Liver failure, infantile, transient | Enrichment | LARS1 | 1.65 |
| 393 | Rubinstein-taybi syndrome 2 | Enrichment | EP300 | 1.65 |
| 394 | Acute myeloid leukemia with maturation | Enrichment | KIT | 1.65 |
| 395 | Nonsyndromic 46,xx testicular disorders/differences of sex development | Enrichment | SOX9 | 1.65 |
| 396 | Hemimegalencephaly | Enrichment | AKT3 | 1.65 |
| 397 | Acute myeloid leukemia with t(8;21)(q22;q22) translocation | Enrichment | KIT | 1.65 |
| 398 | Endometrial stromal sarcoma | Enrichment | YWHAE | 1.65 |
| 399 | Polycystic liver disease | Enrichment | CTNNB1 | 1.65 |
| 400 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1 | 1.65 |
| 401 | Sarcoma, synovial | Enrichment | SS18 | 1.65 |
| 402 | Nail disorder, nonsyndromic congenital, 9 | Enrichment | ARID1B | 1.65 |
| 403 | Coffin-siris syndrome 2 | Enrichment | ARID1A | 1.65 |
| 404 | Umbilical hernia | Enrichment | ACTL6A | 1.65 |
| 405 | Atypical teratoid rhabdoid tumor | Enrichment | SMARCB1 | 1.65 |
| 406 | Periventricular leukomalacia | Enrichment | ARID1A | 1.65 |
| 407 | Schwannomatosis | Enrichment | SMARCB1 | 1.65 |
| 408 | Rasopathy | Enrichment | ATP6V1E1 | 1.64 |
| 409 | Pierre robin syndrome | Enrichment | SOX9 | 1.57 |
| 410 | Branchiooculofacial syndrome | Enrichment | TFAP2A | 1.53 |
| 411 | Aminoacylase 1 deficiency | Enrichment | ACTB | 1.53 |
| 412 | Full schwannomatosis | Enrichment | SMARCB1 | 1.53 |
| 413 | Precursor t-cell acute lymphoblastic leukemia | Enrichment | CDKN2A | 1.52 |
| 414 | Congenital stationary night blindness | Enrichment | TRPM1 | 1.52 |
| 415 | Gastrointestinal stromal tumor | Enrichment | KIT | 1.51 |
| 416 | Megacolon | Enrichment | AKT3 | 1.51 |
| 417 | Fetal akinesia deformation sequence 1 | Enrichment | ASAH1 | 1.49 |
| 418 | Deafness, autosomal recessive | Enrichment | EDNRB, KARS1 | 1.49 |
| 419 | Breast cancer | Enrichment | BRCA1 | 1.49 |
| 420 | Autosomal recessive nonsyndromic deafness | Enrichment | EDNRB, KARS1 | 1.47 |
| 421 | Benign epilepsy with centrotemporal spikes | Enrichment | ASAH1 | 1.45 |
| 422 | Distal arthrogryposis | Enrichment | ASAH1 | 1.44 |
| 423 | Hyperlipidemia, familial combined, 3 | Enrichment | USF1 | 1.43 |
| 424 | Amblyopia | Enrichment | TFAP2A | 1.43 |
| 425 | Centralopathic epilepsy | Enrichment | ASAH1 | 1.43 |
| 426 | Type 2 diabetes mellitus | Enrichment | AKT2, TCF7L2 | 1.40 |
| 427 | Charge syndrome | Enrichment | EP300 | 1.40 |
| 428 | Congenital central hypoventilation syndrome | Enrichment | EDN3 | 1.40 |
| 429 | Peripheral nervous system disease | Enrichment | HINT1 | 1.38 |
| 430 | Neuropathy | Enrichment | HINT1 | 1.38 |
| 431 | Polymicrogyria | Enrichment | AKT3 | 1.36 |
| 432 | Branchiootorenal syndrome 1 | Enrichment | TFAP2A | 1.35 |
| 433 | Wiedemann-steiner syndrome | Enrichment | ARID1B | 1.35 |
| 434 | Inguinal hernia | Enrichment | ACTL6A | 1.35 |
| 435 | 46,xy complete gonadal dysgenesis | Enrichment | SOX9 | 1.32 |
| 436 | Undetermined early-onset epileptic encephalopathy | Enrichment | ATP6V1A | 1.31 |
| 437 | Autism spectrum disorder | Enrichment | ARID1B, SMARCB1, TNRC6B | 1.31 |
| 438 | Branchiootorenal syndrome | Enrichment | TFAP2A | 1.29 |
| 439 | Congenital hydrocephalus | Enrichment | SMARCC1 | 1.29 |
| 440 | Lactic acidosis | Enrichment | KARS1 | 1.28 |
| 441 | Gastroesophageal reflux | Enrichment | ACTL6A | 1.23 |
| 442 | Neuroblastoma | Enrichment | SMARCA4 | 1.23 |
| 443 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | EDNRB, KARS1 | 1.22 |
| 444 | Heart disease | Enrichment | CREBBP | 1.21 |
| 445 | 46,xy partial gonadal dysgenesis | Enrichment | SOX9 | 1.21 |
| 446 | Polydactyly, postaxial, type a1 | Enrichment | EP300 | 1.18 |
| 447 | Ventricular septal defect | Enrichment | SMARCA4 | 1.18 |
| 448 | Myeloma, multiple | Enrichment | CCND1 | 1.14 |
| 449 | Cat eye syndrome | Enrichment | TFAP2A | 1.14 |
| 450 | Heart, malformation of | Enrichment | MAPK1 | 1.11 |
| 451 | Diffuse large b-cell lymphoma | Enrichment | CREBBP | 1.09 |
| 452 | Congenital nervous system abnormality | Enrichment | CREBBP, CTNNB1 | 1.08 |
| 453 | Nervous system disease | Enrichment | CREBBP, CTNNB1 | 1.08 |
| 454 | Epicanthus | Enrichment | TFAP2A | 1.06 |
| 455 | Autism | Enrichment | TCF7L2 | 1.04 |
| 456 | Hypercholesterolemia, familial, 1 | Enrichment | SMARCA4 | 1.03 |
| 457 | Nk-cell enteropathy | Enrichment | SMARCB1 | 1.03 |
| 458 | Tooth agenesis | Enrichment | SUMO1 | 1.02 |
| 459 | Kallmann syndrome | Enrichment | SOX10 | 1.01 |
| 460 | Pituitary stalk interruption syndrome | Enrichment | SMARCA2 | 1.00 |
| 461 | Scoliosis | Enrichment | CREBBP | 0.99 |
| 462 | Myopia | Enrichment | TYR | 0.97 |
| 463 | Familial hypercholesterolemia | Enrichment | SMARCA4 | 0.97 |
| 464 | Cleft palate, isolated | Enrichment | SMARCA4 | 0.92 |
| 465 | Connective tissue disease | Enrichment | SOX9 | 0.87 |
| 466 | Multisystem inflammatory syndrome in children | Enrichment | RAB27A | 0.82 |
| 467 | Skin disease | Enrichment | TYR | 0.82 |
| 468 | Autoinflammatory disease | Enrichment | RAB27A | 0.78 |
| 469 | Hydrops fetalis, nonimmune | Enrichment | ARID1A | 0.75 |
| 470 | Strabismus | Enrichment | TYR | 0.73 |
| 471 | Autosomal dominant non-syndromic intellectual disability | Enrichment | YWHAZ | 0.69 |
| 472 | Non-immune hydrops fetalis | Enrichment | ARID1A | 0.68 |
| 473 | Autosomal recessive non-syndromic intellectual disability | Enrichment | AIMP1 | 0.64 |
| 474 | Dystonia | Enrichment | MYO5A | 0.63 |
| 475 | Eye disease | Enrichment | TYR | 0.63 |
| 476 | Cerebral palsy | Enrichment | SMARCA4 | 0.59 |
| 477 | Hereditary retinal dystrophy | Enrichment | TRPM1 | 0.49 |
| 478 | Fundus dystrophy | Enrichment | TRPM1 | 0.49 |
| 479 | Hypertelorism | Enrichment | TFAP2A | 0.49 |